Personalized RNA Medicine for Pancreatic Cancer

Personalized RNA Medicine for Pancreatic Cancer

Purpose: Since drug responses vary between patients, it is crucial to develop pre-clinical or co-clinical strategies that forecast patient response. In this study, we tested whether RNA-based therapeutics were suitable for personalized medicine by using patient-derived-organoid (PDO) and patient-der...

Full description

Bibliographic Details
Main Authors: Gilles, Maud-Emmanuelle, Hao, Liangliang, Huang, Ling, Rupaimoole, Rajesha, Lopez-Casas, Pedro P., Pulver, Emilia M, Jeong, Jong Cheol, Muthuswamy, Senthil K., Hidalgo, Manuel, Bhatia, Sangeeta N, Slack, Frank J.
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format: Article
Language:English
Published: American Association for Cancer Research (AACR) 2020
Online Access:https://hdl.handle.net/1721.1/128860

Internet

https://hdl.handle.net/1721.1/128860

Similar Items